Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

PRESS: The Rise of Goodwin (<i>Private Equity Magazine</i>)

PRESS: The Rise of Goodwin (Private Equity Magazine)

Related Content

What’s on the Horizon for Aerospace and Defense? A Download Après the Paris Air Show/Le Bourget

One Big Beautiful Bill Act – Tax Highlights related to Research and Experimental Expenditures, Qualified Small Business Stock and Business Interest Expense Deductions

How to Write an Effective Public Benefit Report

“They Will Thank Me in the Long Run”: Court of Appeal Considers Good Faith Obligations and Fiduciary Duties of Directors in Relation to Shareholder Exit Provisions

Oregon Governor Signs Law Aggressively Restricting Private Equity Investment in Medical Practices

Crafting a Competitive LOI in Lower Middle Market M&A

Washington Becomes First State to Adopt Filing Requirements for HSR-Reportable Transactions Outside of Healthcare

Five Trends Reshaping Pharmaceutical Manufacturing Partnerships

Parquest to Sell Sopral to IPN

Goodwin Advises GREENPEAK Partners Portfolio Company encoviva on the Acquisition Financing of ING.FTG

Goodwin Strengthens its European Private Equity Platform with Debt Finance Partner Tom Roberts

Goodwin Is Number One Law Firm for Global M&A for H1 2025

Triton to Acquire Prenax

Goodwin Advises INTEC on Financing for the Acquisition of a Majority Stake in Three Companies of ARBOR Group

Katherine Baudistel Recognized by Los Angeles Business Journal’s 2025 Leaders of Influence in Private Equity

Goodwin Advised Landmark Bio in Acquisition by Artis BioSolutions to Expand Manufacturing and Commercialization of Advanced Therapies

Private Equity

Private Equity France

Tax